Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2020 Filed Feb 5, 2020 22:55 UTC |
Behbahani AliDirector
|
ConversionCommon Stock | 2,176,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-007022 · doc4.xml · nonDerivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 2,176,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series B Preferred Stock had no expiration date. F2 · ownership.nature: The Reporting Person is a manager of NEA 16 GP, LLC, ("NEA 16 GP") which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:55 UTC |
Leggett ThomasChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 55,540 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0000899243-20-002446 · doc4.xml · derivative · entry 1 Leggett Thomas · CIK 0001774690 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,540 Underlying: Common Stock · 55,540 shares Expires 2030-01-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:52 UTC |
Roberts Christopher D.Chief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 54,711 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0000899243-20-002444 · doc4.xml · derivative · entry 1 Roberts Christopher D. · CIK 0001788368 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,711 Underlying: Common Stock · 54,711 shares Expires 2030-01-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:51 UTC |
Epstein David M.Director · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 278,532 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0000899243-20-002442 · doc4.xml · derivative · entry 1 Epstein David M. · CIK 0001488668 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,532 Underlying: Common Stock · 278,532 shares Expires 2030-01-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:50 UTC |
Hatzis-Schoch BrentSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 78,751 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0000899243-20-002440 · doc4.xml · derivative · entry 1 Hatzis-Schoch Brent · CIK 0001637054 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,751 Underlying: Common Stock · 78,751 shares Expires 2030-01-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.